- Global Pharma News & Resources

Merck to Host Investor Briefing to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the company will host a virtual investor event to discuss Merck’s broad HIV program and the newly announced collaboration with Gilead Sciences.

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at Institutional investors and analysts who would like to ask a question during the session, please dial in using the information on the events page and follow the operator’s instructions.

Editor Details

Related Links

Last Updated: 16-Mar-2021